Literature DB >> 18603548

Impaired differentiation and apoptosis of hematopoietic precursors in a mouse model of myelodysplastic syndrome.

Chul Won Choi1, Yang Jo Chung, Christopher Slape, Peter D Aplan.   

Abstract

Expression of a NUP98-HOXD13 (NHD13) fusion gene, initially identified in a patient with myelodysplastic syndrome, leads to a highly penetrant myelodysplastic syndrome in mice that recapitulates all of the key features of the human disease. Expansion of undifferentiated lineage negative (lin(neg)) hematopoietic precursors that express NHD13 was markedly inhibited (30-fold) in vitro. Decreased expansion was accompanied by decreased production of terminally differentiated cells, indicating impaired differentiation of NHD13 precursors. Rather than differentiate, the majority (80%) of NHD13 lin(neg) precursors underwent apoptotic cell death when induced to differentiate. These findings demonstrate that NHD13 lin(neg) cells provide a tractable in vitro system for studies of myelodysplastic syndrome.

Entities:  

Mesh:

Year:  2008        PMID: 18603548      PMCID: PMC2575012          DOI: 10.3324/haematol.13042

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  19 in total

Review 1.  Apoptosis and its significance in MDS: controversies revisited.

Authors:  Y Yoshida; G J Mufti
Journal:  Leuk Res       Date:  1999-09       Impact factor: 3.156

2.  p53-independent apoptosis associated with c-Myc-mediated block in myeloid cell differentiation.

Authors:  A Amanullah; D A Liebermann; B Hoffman
Journal:  Oncogene       Date:  2000-06-15       Impact factor: 9.867

Review 3.  Myelodysplasia.

Authors:  M L Heaney; D W Golde
Journal:  N Engl J Med       Date:  1999-05-27       Impact factor: 91.245

Review 4.  The role of apoptosis in the pathogenesis of the myelodysplastic syndromes.

Authors:  Jane E Parker; Ghulam J Mufti
Journal:  Int J Hematol       Date:  2001-06       Impact factor: 2.490

5.  Comparative analysis of the in vitro proliferation and expansion of hematopoietic progenitors from patients with aplastic anemia and myelodysplasia.

Authors:  Guadalupe Martínez-Jaramillo; Eugenia Flores-Figueroa; Elizabeth Sánchez-Valle; Guillermo Gutiérrez-Espíndola; Enrique Gómez-Morales; Juan José Montesinos; Patricia Flores-Guzmán; Antonieta Chávez-González; J Antonio Alvarado-Moreno; Hector Mayani
Journal:  Leuk Res       Date:  2002-10       Impact factor: 3.156

6.  A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome.

Authors:  G M Gersuk; C Beckham; M R Loken; P Kiener; J E Anderson; A Farrand; A B Troutt; J A Ledbetter; H J Deeg
Journal:  Br J Haematol       Date:  1998-10       Impact factor: 6.998

Review 7.  The role of NUP98 gene fusions in hematologic malignancy.

Authors:  Christopher Slape; Peter D Aplan
Journal:  Leuk Lymphoma       Date:  2004-07

8.  Erythroid and granulocyte-macrophage colony formation in myelodysplastic syndromes.

Authors:  T Ruutu; S Partanen; R Lintula; L Teerenhovi; S Knuutila
Journal:  Scand J Haematol       Date:  1984-04

9.  Significance of in vitro cultures in myelodysplastic syndromes.

Authors:  H L Haak; H Kerkhofs; J S van der Linden; H Schonewille; H S van der Sanden-van der Meer; J Hermans
Journal:  Scand J Haematol       Date:  1986-11

Review 10.  Impaired proliferation and differentiation of myelodysplastic CD34+ cells.

Authors:  K Sawada
Journal:  Leuk Lymphoma       Date:  1994-06
View more
  16 in total

1.  Genome architecture marked by retrotransposons modulates predisposition to DNA methylation in cancer.

Authors:  Marcos R H Estécio; Juan Gallegos; Céline Vallot; Ryan J Castoro; Woonbok Chung; Shinji Maegawa; Yasuhiro Oki; Yutaka Kondo; Jaroslav Jelinek; Lanlan Shen; Helge Hartung; Peter D Aplan; Bogdan A Czerniak; Shoudan Liang; Jean-Pierre J Issa
Journal:  Genome Res       Date:  2010-08-17       Impact factor: 9.043

Review 2.  NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights.

Authors:  Sheryl M Gough; Christopher I Slape; Peter D Aplan
Journal:  Blood       Date:  2011-09-26       Impact factor: 22.113

Review 3.  Mouse models of myelodysplastic syndromes.

Authors:  Sarah H Beachy; Peter D Aplan
Journal:  Hematol Oncol Clin North Am       Date:  2010-04       Impact factor: 3.722

4.  Loss of Toll-like receptor 2 results in accelerated leukemogenesis in the NUP98-HOXD13 mouse model of MDS.

Authors:  Darlene A Monlish; Sima T Bhatt; Eric J Duncavage; Zev J Greenberg; John L Keller; Molly P Romine; Wei Yang; Peter D Aplan; Matthew J Walter; Laura G Schuettpelz
Journal:  Blood       Date:  2018-01-22       Impact factor: 22.113

5.  Oxidative stress leads to increased mutation frequency in a murine model of myelodysplastic syndrome.

Authors:  Yang Jo Chung; Carine Robert; Sheryl M Gough; Feyruz V Rassool; Peter D Aplan
Journal:  Leuk Res       Date:  2013-08-16       Impact factor: 3.156

Review 6.  Engineering mouse models with myelodysplastic syndrome human candidate genes; how relevant are they?

Authors:  Stephanie Beurlet; Christine Chomienne; Rose Ann Padua
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

7.  Transplantation of a myelodysplastic syndrome by a long-term repopulating hematopoietic cell.

Authors:  Yang Jo Chung; Chul Won Choi; Christopher Slape; Terry Fry; Peter D Aplan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-03       Impact factor: 11.205

8.  Unimpaired terminal erythroid differentiation and preserved enucleation capacity in myelodysplastic 5q(del) clones: a single cell study.

Authors:  Laurent Garderet; Ladan Kobari; Christelle Mazurier; Caroline De Witte; Marie-Catherine Giarratana; Christine Pérot; Norbert Claude Gorin; Hélène Lapillonne; Luc Douay
Journal:  Haematologica       Date:  2009-10-08       Impact factor: 9.941

9.  Targeting of the bone marrow microenvironment improves outcome in a murine model of myelodysplastic syndrome.

Authors:  Sophia R Balderman; Allison J Li; Corey M Hoffman; Benjamin J Frisch; Alexandra N Goodman; Mark W LaMere; Mary A Georger; Andrew G Evans; Jane L Liesveld; Michael W Becker; Laura M Calvi
Journal:  Blood       Date:  2015-12-04       Impact factor: 22.113

10.  Depletion of cytotoxic T-cells does not protect NUP98-HOXD13 mice from myelodysplastic syndrome but reveals a modest tumor immunosurveillance effect.

Authors:  Sheryl M Gough; Yang Jo Chung; Peter D Aplan
Journal:  PLoS One       Date:  2012-05-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.